Primary gastrointestinal follicular lymphoma: single-center 12-year experiences

Hepatogastroenterology. 2012 May;59(115):751-3. doi: 10.5754/hge11569.

Abstract

Background/aims: Primary gastrointestinal follicular lymphoma (GI-FL) is very rare and its natural course is barley known. This study aimed to evaluate the clinical characteristics of primary gastrointestinal follicular lymphoma (GI-FL).

Methodology: From May 1996 to October 2008, the records of five patients diagnosed with primary GI-FL were retrieved from pathological files and retrospectively analyzed in terms of characteristics of endoscopic and clinical findings.

Results: The five patients consisted of 3 males and 2 females with a median age of 52 years. Abdominal pain was the most common (n=4, 80%) symptom. The most frequent site was the terminal ileum in the small bowel (n=3, 60%). Endoscopic findings were 3 of mass forming type, 1 of irregular ulcer type and 1 of whitish granular type. Three cases (60%) had a component of diffuse large B cell lymphoma. All cases received chemotherapy. While complete remission occurred in every patient, relapse occurred in the two patients with a higher grade and more advanced stage than the other cases. At a median follow-up time of 37 months (range, 27-58 months; mean, 38.8 months), four patients (80%) were disease free and one patient had died of cardiovascular disease.

Conclusions: In South Korea, primary gastrointestinal follicular lymphoma is very rare and symptomatic. Endoscopic findings were variable from early whitish granular lesions to advanced mass forming lesions.

MeSH terms

  • Abdominal Pain / etiology
  • Adolescent
  • Adult
  • Antineoplastic Agents / therapeutic use
  • Disease-Free Survival
  • Endoscopy, Gastrointestinal
  • Female
  • Gastrointestinal Neoplasms* / complications
  • Gastrointestinal Neoplasms* / drug therapy
  • Gastrointestinal Neoplasms* / mortality
  • Gastrointestinal Neoplasms* / pathology
  • Humans
  • Lymphoma, Follicular* / complications
  • Lymphoma, Follicular* / drug therapy
  • Lymphoma, Follicular* / mortality
  • Lymphoma, Follicular* / pathology
  • Lymphoma, Large B-Cell, Diffuse* / complications
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / mortality
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Neoplasms, Complex and Mixed*
  • Recurrence
  • Remission Induction
  • Republic of Korea
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents